Description
Viropil Tablets: A Triple-Action Antiretroviral Therapy
Viropil Anti-HIV Tablets are a highly effective fixed-dose combination (FDC) therapy used in the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults and adolescents. This convenient, once-daily regimen is prized for its strong efficacy and adherence profile.
The tablet combines three distinct antiretroviral agents, each targeting a different stage of the viral life cycle:
| Component | Strength | Class of Drug | Primary Mechanism of Action |
| Dolutegravir (DTG) | 50 mg | Integrase Strand Transfer Inhibitor (INSTI) | Inhibits the HIV Integrase enzyme, preventing the viral DNA from integrating into the host cell’s genome. |
| Lamivudine (3TC) | 300mg | Nucleoside Reverse Transcriptase Inhibitor (NRTI) | Blocks the HIV Reverse Transcriptase enzyme, preventing the virus from converting its RNA into DNA. |
| Tenofovir Disoproxil Fumarate (TDF) | 300mg | Nucleotide Reverse Transcriptase Inhibitor (NtRTI) | A prodrug that targets and inhibits the same reverse transcriptase enzyme as 3TC. |
Clinical Use and Efficacy
Together, these components work synergistically to provide comprehensive viral suppression.3 This action effectively halts the HIV virus’s ability to multiply. Consequently, this leads to a rapid reduction in the viral load to undetectable levels and plays a crucial role in helping restore immune function (indicated by increased CD4 cell counts).
Viropil is typically taken once daily, with or without food.4 Adherence to this therapy is crucial for two main reasons: maintaining effective viral suppression and, more importantly, avoiding the emergence of drug resistance, which could compromise future treatment options.
Manufacturing, Safety, and Monitoring
Emcure Pharmaceuticals, a leading company in the development of antiretroviral medications, manufactures Viropil Anti-HIV Tablets.
| Common Side Effects | Important Safety and Monitoring | Clinical Relevance |
| Headache, insomnia, nausea, diarrhea, and fatigue. | Renal Impairment: The TDF component is associated with a risk of kidney function changes, requiring close monitoring. | Regular monitoring of serum creatinine and creatinine clearance is essential during therapy. |
| Lactic Acidosis and Severe Hepatomegaly: Rare but serious adverse effects associated with NRTI class drugs (3TC and TDF). | Patient education on symptoms like unusual muscle pain or shortness of breath is critical. | |
| Severe Acute Exacerbation of Hepatitis B (HBV): Since TDF and 3TC are active against HBV, patients co-infected with HIV/HBV must be closely monitored for liver function if the medication is stopped. | Liver Function: Periodic monitoring of liver enzymes is necessary. | |
| Hypersensitivity Reactions: DTG carries a low risk of severe allergic reactions. | Discontinuation is required if signs of rash or systemic symptoms (fever, malaise) develop. |
Availability & Purchase Information
Genetec Lifesciences makes Viropil Anti-HIV Tablets available. All products are sourced directly from Emcure or authorized vendors.
Disclaimer
This site provides product information for informative purposes only. The product image belongs to its respective company. Genetec Lifesciences acts as a wholesaler and distributor, not a manufacturer.6 We source our medicines directly from the company or authorized vendors of the company.